Apollon Wealth Management LLC Lowers Stock Holdings in CVS Health Co. (NYSE:CVS)

Apollon Wealth Management LLC lessened its holdings in CVS Health Co. (NYSE:CVS) by 0.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 33,364 shares of the pharmacy operator’s stock after selling 271 shares during the quarter. Apollon Wealth Management LLC’s holdings in CVS Health were worth $1,498,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health during the third quarter worth approximately $25,000. Ridgewood Investments LLC lifted its holdings in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the 3rd quarter worth $31,000. Legacy Investment Solutions LLC purchased a new position in shares of CVS Health during the 3rd quarter worth approximately $31,000. Finally, Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the 3rd quarter worth $32,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have issued reports on CVS. Mizuho cut their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. TD Cowen upped their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Piper Sandler reduced their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research report on Monday, November 25th. Finally, Edward Jones upgraded CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. One analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $68.12.

CVS Health Stock Up 0.4 %

CVS stock opened at $54.24 on Tuesday. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a market cap of $68.26 billion, a PE ratio of 13.77, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. The firm’s 50-day simple moving average is $50.79 and its 200 day simple moving average is $55.98.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.90%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.